Cardiovascular Diseases Research in Georgia
Cardiovascular Diseases Research (93.837) awarded $383 million to recipients in Georgia in 338 grants from fiscal 2021 to 2025, 2.6% of the program's national total. Emory University received the most, $211 million.
- Awarded in Georgia$383 million
- Awards338
- Share of the program2.6%
- Rank among states12th of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 175 | $77.9 million |
| FY 2022 | 162 | $72.5 million |
| FY 2023 | 167 | $74.2 million |
| FY 2024 | 170 | $79.4 million |
| FY 2025 | 155 | $78.6 million |
Recipients in Georgia
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Emory University | Colleges and universities | 194 | $211 million |
| Augusta University Research Institute, Inc | Nonprofits | 73 | $106 million |
| Georgia State University Research Foundation Inc | Nonprofits | 16 | $17.3 million |
| University of Georgia Research Foundation, Inc. | Nonprofits | 17 | $17.2 million |
| Georgia Tech Research Corp | Colleges and universities | 17 | $15.6 million |
| Annoviant, Inc | Small businesses | 1 | $4.0 million |
| Sanguina Inc | Small businesses | 2 | $3.4 million |
| Nytricx, Inc. | Small businesses | 2 | $2.7 million |
| The Corporation of Mercer University | Colleges and universities | 4 | $2.0 million |
| Kennesaw State University | Colleges and universities | 2 | $928,962 |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 82 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to Georgia?
$383 million from fiscal 2021 to 2025, across 338 awards. Georgia ranks 12th of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in Georgia?
The largest recipient is Emory University, with $211 million in 194 awards. Next are Augusta University Research Institute, Inc and Georgia State University Research Foundation Inc.
Can organizations in Georgia apply now?
Yes, 82 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in Georgia
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- 1332 State Innovation Waivers
- Children's Health Insurance Program
- Special Education Grants to States
- Temporary Assistance for Needy Families